Microenvironmental barriers to healing in osteoradionecrosis and opportunities for regenerative intervention.
4 affiliations
- 1Thayer School of Engineering, Dartmouth College, Hanover, NH, United States.
- 2The Orthopaedic Trauma Institute, University of California, San Francisco (UCSF), San Francisco, CA, United States.
- 3Center for Regenerative and Personalized Medicine, Steadman Philippon Research Institute, Vail, CO, United States.
- 4Geisel School of Medicine, Dartmouth College, Hanover, NH, United States.
Abstract
Osteoradionecrosis (ORN) is a debilitating sequela of radiotherapy (RT) for head and neck cancer (HNC), characterized by persistent bone exposure or radiographic non-viability and profound tissue repair failure. Despite advances in radiation delivery and clinical management, ORN remains challenging to treat, with therapeutic strategies largely focused on symptom control, infection mitigation, or surgical reconstruction rather than restoration of regenerative capacity. Emerging evidence suggests that radiation-induced cellular senescence represents a central and underrecognized driver of ORN pathophysiology. Ionizing radiation disrupts the bone microenvironment through sustained vascular injury, impaired osteogenic-angiogenic coupling, chronic inflammation, and the accumulation of senescent bone-resident and stromal cells that secrete a pro-inflammatory senescence-associated secretory phenotype (SASP). Together, these changes create a hostile niche that suppresses bone remodeling and wound healing long after radiation exposure. This review synthesizes current understanding of radiation-induced injury to the bone microenvironment, critically evaluates existing classification systems and treatment strategies for ORN, and examines emerging regenerative approaches. We further propose senotherapeutic strategies targeting radiation-induced cellular senescence as a complementary and potentially transformative avenue to restore tissue repair capacity. By integrating regenerative biomaterials with targeted modulation of senescence, future therapies may move beyond palliation toward true biological resolution of ORN. Biomaterial delivery systems (e.g., injectable hydrogels, mineral composite scaffolds, and cryogel platforms) are emerging as promising vehicles for spatiotemporally controlled senotherapeutic delivery within the irradiated bone niche.
Related
- Chronic Inflammation, Fibrotic Remodeling, and Regenerative Failure in Duchenne Muscular Dystrophy: Mechanisms and Therapeutic Opportunities
- Cathepsin L in cancer: Context‐dependent functions, microenvironmental regulation and translational opportunities
- Astragaloside IV and tumor microenvironmental barriers: immune mechanisms, evidence hierarchy, and implications for checkpoint blockade
- Modeling the Microenvironmental Dynamics of Adenoid Cystic Carcinoma in Lacrimal Gland with Treatment Intervention
- Opportunities to Address Barriers to Enrollment in Food is Medicine Programs: Lessons Learned From the SUPeRFOOD Trial
BibTeX
@article{croix2026microenvironmental,
title = {{Microenvironmental barriers to healing in osteoradionecrosis and opportunities for regenerative intervention.}},
author = {Aleyna E La Croix and Maria Eduarda Torres Gouveia and Peter M Bertone and Neva M Nemanic and Chelsea S Bahney and Katherine R Hixon},
journal = {Bioactive materials},
year = {2026},
month = oct,
doi = {10.1016/j.bioactmat.2026.09.020},
url = {https://europepmc.org/article/MED/42910095},
note = {CC BY},
}
RIS
TY - JOUR
TI - Microenvironmental barriers to healing in osteoradionecrosis and opportunities for regenerative intervention.
AU - Aleyna E La Croix
AU - Maria Eduarda Torres Gouveia
AU - Peter M Bertone
AU - Neva M Nemanic
AU - Chelsea S Bahney
AU - Katherine R Hixon
PY - 2026
DA - 2026/10/13
JO - Bioactive materials
DO - 10.1016/j.bioactmat.2026.09.020
UR - https://europepmc.org/article/MED/42910095
AB - Osteoradionecrosis (ORN) is a debilitating sequela of radiotherapy (RT) for head and neck cancer (HNC), characterized by persistent bone exposure or radiographic non-viability and profound tissue repair failure. Despite advances in radiation delivery and clinical management, ORN remains challenging to treat, with therapeutic strategies largely focused on symptom control, infection mitigation, or surgical reconstruction rather than restoration of regenerative capacity. Emerging evidence suggests that radiation-induced cellular senescence represents a central and underrecognized driver of ORN pathophysiology. Ionizing radiation disrupts the bone microenvironment through sustained vascular injury, impaired osteogenic-angiogenic coupling, chronic inflammation, and the accumulation of senescent bone-resident and stromal cells that secrete a pro-inflammatory senescence-associated secretory phenotype (SASP). Together, these changes create a hostile niche that suppresses bone remodeling and wound healing long after radiation exposure. This review synthesizes current understanding of radiation-induced injury to the bone microenvironment, critically evaluates existing classification systems and treatment strategies for ORN, and examines emerging regenerative approaches. We further propose senotherapeutic strategies targeting radiation-induced cellular senescence as a complementary and potentially transformative avenue to restore tissue repair capacity. By integrating regenerative biomaterials with targeted modulation of senescence, future therapies may move beyond palliation toward true biological resolution of ORN. Biomaterial delivery systems (e.g., injectable hydrogels, mineral composite scaffolds, and cryogel platforms) are emerging as promising vehicles for spatiotemporally controlled senotherapeutic delivery within the irradiated bone niche.
SN - 2452-199X
ER -